2002, Number 3
<< Back Next >>
Gac Med Mex 2002; 138 (3)
Forty Six-Year-Old Woman with Clinical Characteristics of Excesive Growth Hormone.
Espinosa-de los Monteros AL, Marín JL, Abaroa AR, Ovalle EA, Sosa E, Mercado M
Language: Spanish
References: 14
Page: 267-270
PDF size: 124.10 Kb.
Text Extraction
No abstract
REFERENCES
Melmed S,Ho K, Klibanski A, et al. Recent advances in pathogenesis, diagnosis and management of acromegaly. J Clin Endocrinol Metab 1995;80:3395-402.
Ezzat S, Forster MJ, Berchtold P, et al. Acromegaly: clinical and biochemical features in 500 patients. Medicine (Baltimore) 1994;73:233-40.
Molitch ME. Clinical manifestation of acromegaly. Endocrinol Metab Clin North Am 1992;21:597-614.
Chang-DeMoranville BM, Jackson IMD. Diagnosis and endocrine testing in acromegaly. Endocrinol Metab Clin North Am 1992;21:649-68.
Klein I, Levey GS. Unusual manifestations of hypothyroidism. Arch Intern Med 1984;144:123-8.
Samaan NA. Hypoglycemia secondary to endocrine deficiencies. Endocrinol Metab Clin North Am 1989;18:145-54.
Faglia G, Arosio M, Bazzoni M. Ectopic acromegaly. Endocrinol Metab Clin North Am 1992;21:575-96.
Beuschlein F, Strasburger CJ, Siegerstetter V, et al. Acromegaly caused by secretion of growth hormone by a non-Hodgkin’s lymphoma. N Engl J Med 2000;342:1871-6.
Flier JS, Moller DE, Moses AC, et al. Insulin-mediated pseudoacromegaly: clinical and biochemical characterization of a syndrome of selective insulin resistance. J Clin Endocrinol Metab 1993;76:1533-41.
Krook AS, Kumar I, Laing AJM, et al. Molecular scanning of the insulin receptor gene in syndromes of insulin resistance. Diabetes 1994;43:357-68.
Kumar S, Durrington PM, O’Rahilly S, et al. Severe insulin resistance, diabetes mellitus, hypertriglyceridemia and pseudoacromegaly. J Clin Endocrinol Metab 1996;81:3465-8.
Dib K, Whitehead JP, Humphreys PJ, et al. Impaired activation of phosphoinositide 3-kinase by insulin in fibroblasts from patients with severe insulin resistance and pseudoacromegaly. A disorder characterized by selective postreceptor insulin resistance. J Clin Invest 1998;101:1111-20.
Chapman IM, Hartman ML, Straume M, et al. Enhanced sensitivity growth hormone (GH) chemiluminescence assay reveals lower post-glucose nadir GH concentrations in men than women. J Clin Endocrinol Metab 1994;78:1312-19.
Dimaraki EV, Jaffe CA, DeMott-Frieberg R, et al. Micromegaly: active acromegaly with normal GH levels. Implications for diagnostic and follow-up criteria. Abstract P3-658. 81st Annual Meeting of the Endocrine Society. San Diego CA, USA 1999.
Full text